FDA authorizes Abbott's wearable to monitor ketone and glucose in diabetes patients

The biowearable is designed to ‌alert ⁠people of rising ketones that can ⁠lead to a diabetic ketoacidosis (DKA) emergency, a serious health complication for people with diabetes